Holen Sie sich die Stockscreener-App
0.00
100.00%
-1.27
Handel nachbörslich:
1.28
1.28
+
Schlusskurs vom Vortag:
$1.27
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$76.57M
Einnahmen:
$2.91M
Nettoeinkommen (Verlust:
$-220.40M
KGV:
0.00
EPS:
-3.64
Netto-Cashflow:
$-176.15M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
Firmenname
Igm Biosciences Inc
Sektor
Branche
Telefon
650-965-7873
Adresse
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Vergleichen Sie IGMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
0.00 | 76.57M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-01-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-10-01 | Herabstufung | Truist | Buy → Hold |
| 2024-02-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | Fortgesetzt | Jefferies | Buy |
| 2022-10-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2021-12-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2021-08-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-22 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-07-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-07-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-28 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Wedbush | Outperform |
| 2019-10-14 | Eingeleitet | Guggenheim | Buy |
| 2019-10-14 | Eingeleitet | Jefferies | Buy |
| 2019-10-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-10-14 | Eingeleitet | Stifel | Buy |
Alle ansehen
Igm Biosciences Inc Aktie (IGMS) Neueste Nachrichten
Can IGM Biosciences Inc. hit a new high this monthJuly 2025 Setups & High Yield Equity Trading Tips - Newser
How to build a custom watchlist for IGM Biosciences Inc.July 2025 Trends & Stepwise Trade Signal Implementation - Newser
Is now a turning point for IGM Biosciences Inc.Trade Volume Report & Risk Controlled Stock Pick Alerts - Newser
Analyzing drawdowns of IGM Biosciences Inc. with statistical tools2025 Market Trends & Technical Buy Zone Confirmation - Newser
IGM Biosciences Inc. stock daily chart insights2025 Volatility Report & Smart Allocation Stock Tips - Newser
IGM Biosciences Inc. stock trend outlook and recovery pathIPO Watch & Weekly Chart Analysis and Trade Guides - Newser
How to track smart money flows in IGM Biosciences Inc.Dividend Hike & Low Drawdown Trading Strategies - Newser
Can momentum traders help lift IGM Biosciences Inc.July 2025 Levels & Weekly Return Optimization Alerts - Newser
Can IGM Biosciences Inc. recover in the next quarterInsider Buying & Safe Capital Investment Plans - Newser
Advanced analytics toolkit walkthrough for IGM Biosciences Inc.Quarterly Growth Report & High Accuracy Investment Entry Signals - Newser
Applying chart zones and confluence areas to IGM Biosciences Inc.CEO Change & Smart Swing Trading Alerts - Newser
Will IGM Biosciences Inc. benefit from macro trends2025 Trading Recap & Capital Efficiency Focused Ideas - Newser
Using AI based signals to follow IGM Biosciences Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - Newser
Institutional scanner results for IGM Biosciences Inc.Oil Prices & Short-Term High Return Ideas - Newser
IGM Biosciences Inc. Testing Reversal Zone on Weekly ChartJuly 2025 Momentum & Weekly Hot Stock Watchlists - classian.co.kr
What institutional flow reveals about IGM Biosciences Inc.CEO Change & Short-Term High Return Ideas - Newser
Is IGM Biosciences Inc. stock a top performer YTDWeekly Risk Summary & Stepwise Entry and Exit Trade Signals - 더경남뉴스
Will IGM Biosciences Inc. benefit from government policyJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - sundaytimes.kr
Analyst Downgrade: What is the next catalyst for IGM Biosciences Inc.Weekly Gains Summary & Consistent Profit Trade Alerts - theviewers.co.kr
IGM Biosciences Inc. Matches Institutional Buying FilterEarnings Trend Report & High Conviction Investment Ideas - Newser
How does IGM Biosciences Inc. compare to its peersJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - theviewers.co.kr
Applying Elliott Wave Theory to IGM Biosciences Inc.2025 Price Targets & AI Driven Stock Movement Reports - Newser
Published on: 2025-08-21 19:13:27 - 더경남뉴스
IGM Biosciences Inc. Moves Into Bullish Territory Based on MACDQuarterly Profit Report & Daily Entry Point Alerts - 더경남뉴스
Wall Street Zen Upgrades IGM Biosciences (NASDAQ:IGMS) to "Hold" - MarketBeat
How to manage a losing position in IGM Biosciences Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
IGM Biosciences Q2 2025 Earnings Miss: Persistent Losses and Mixed Market Implications - AInvest
Why IGM Biosciences Inc. is moving today2025 Geopolitical Influence & Growth Focused Entry Reports - Newser
Chart overlay techniques for tracking IGM Biosciences Inc.July 2025 Closing Moves & Weekly High Return Forecasts - Newser
Using RSI to spot recovery in IGM Biosciences Inc.July 2025 Opening Moves & Community Verified Watchlist Alerts - Newser
Volume spikes in IGM Biosciences Inc. stock – what they mean2025 Big Picture & Low Risk Entry Point Tips - Newser
Is IGM Biosciences Inc. a speculative investmentTrade Entry Report & Low Risk High Reward Ideas - newsimpact.co.kr
What makes IGM Biosciences Inc. stock price move sharplyQuarterly Performance Summary & Technical Entry and Exit Tips - Newser
Volatility clustering patterns for IGM Biosciences Inc.2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Can IGM Biosciences Inc. disrupt its industryMarket Trend Report & Target Return Focused Stock Picks - thegnnews.com
Wall Street Zen Upgrades IGM Biosciences (NASDAQ:IGMS) to Hold - Defense World
Using Ichimoku Cloud for IGM Biosciences Inc. technicalsJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser
Is IGM Biosciences Inc. a candidate for recovery playWeekly Earnings Recap & Safe Entry Momentum Tips - Newser
Is IGM Biosciences (IGMS) a High-Risk Bet in a Downcycle Biotech Sector? - AInvest
Finanzdaten der Igm Biosciences Inc-Aktie (IGMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):